Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 1,079

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

The Insulin-Like Growth Factor-Binding Protein (IGFBP) Superfamily*

Hwa, Vivian, Oh, Youngman, Rosenfeld, Ron G.·1999·Endocrine Reviews

Abstract

Over the last decade, the concept of an IGFBP family has been well accepted, based on structural similarities and on functional abilities to bind IGFs with high affinities. The existence of other potential IGFBPs was left open. The discovery of proteins with N-terminal domains bearing striking structural similarities to the N terminus of the IGFBPs, and with reduced, but demonstrable, affinity for IGFs, raised the question of whether these proteins were "new" IGFBPs (22, 23, 217). The N-terminal domain had been uniquely associated with the IGFBPs and has long been considered to be critical for IGF binding. No other function has been confirmed for this domain to date. Thus, the presence of this important IGFBP domain in the N terminus of other proteins must be considered significant. Although these other proteins appear capable of binding IGF, their relatively low affinity and the fact that their major biological actions are likely to not directly involve the IGF peptides suggest that they probably should not be classified within the IGFBP family as provisionally proposed (22, 23). The conservation of this single domain, so critical to high-affinity binding of IGF by the six IGFBPs, in all of the IGFBP-rPs, as well, speaks to its biological importance. Historically, and perhaps, functionally, this has led to the designation of an "IGFBP superfamily". The classification and nomenclature for the IGFBP superfamily, are, of course, arbitrary; what is ultimately relevant is the underlying biology, much of which still remains to be deciphered. The nomenclature for the IGFBP related proteins was derived from a consensus of researchers working in the IGFBP field (52). Obviously, a more general consensus on nomenclature, involving all groups working on each IGFBP-rP, has yet to be reached. Further understanding of the biological functions of each protein should help resolve the nomenclature dilemma. For the present, redesignating these proteins IGFBP-rPs simplifies the multiple names already associated with each IGFBP related protein, and reinforces the concept of a relationship with the IGFBPs. Beyond the N-terminal domain, there is a lack of structural similarity between the IGFBP-rPs and IGFBPs. The C-terminal domains do share similarities to other internal domains found in numerous other proteins. For example, the similarity of the IGFBP C terminus to the thyroglobulin type-I domain shows that the IGFBPs are also structurally related to numerous other proteins carrying the same domain (87). Interestingly, the functions of the different C-terminal domains in members of the IGFBP superfamily include interactions with the cell surface or ECM, suggesting that, even if they share little sequence similarities, the C-terminal domains may be functionally related. The evolutionary conservation of the N-terminal domain and functional studies support the notion that IGFBPs and IGFBP-rPs together form an IGFBP superfamily. A superfamily delineates between closely related (classified as a family) and distantly related proteins. The IGFBP superfamily is therefore composed of distantly related families. The modular nature of the constituents of the IGFBP superfamily, particularly their preservation of an highly conserved N-terminal domain, seems best explained by the process of exon shuffling of an ancestral gene encoding this domain. Over the course of evolution, some members evolved into high-affinity IGF binders and others into low-affinity IGF binders, thereby conferring on the IGFBP superfamily the ability to influence cell growth by both IGF-dependent and IGF-independent means (Fig. 10). A final word, from Stephen Jay Gould (218): "But classifications are not passive ordering devices in a world objectively divided into obvious categories. Taxonomies are human decisions imposed upon nature--theories about the causes of nature's order. The chronicle of historical changes in classification provides our finest insight into conceptual revolutions

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/edrv.20.6.0382

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 213

  1. Salmon, 1957, A hormonally controlled serum factor which stimulates sulfation incorporation by cartilage in vitro., J Lab Clin Med, 49, 825
  2. Froesch, 1966, Nonsuppressible insulin-like activity of human serum. II. Biological properties of plasma extracts with nonsuppressible insulin-like activity., Biochim Biophys Acta, 121, 360, 10.1016/0304-4165(66)90125-5 · DOI
  3. Dulak, 1973, A partially purified polypeptide fraction from rat liver cell conditioned medium with multiplication-simulating activity fro embryo fibroblasts., J Cell Physiol, 81, 153, 10.1002/jcp.1040810204 · DOI · Paper page
  4. Daughaday, 1972, Somatomedin: proposed designation for sulphation factor., Nature, 235, 107, 10.1038/235107a0 · DOI · Paper page
  5. Daughaday, 1989, Insulin-like growth factors I and II peptide messenger ribonucleic acid and gene structures, serum and tissue concentrations., Endocr Rev, 10, 68, 10.1210/edrv-10-1-68 · DOI · Paper page
  6. Rosenfeld, 1986, Insulin-like growth factors I and II in the evaluation of growth retardation., J Pediatr, 109, 428, 10.1016/S0022-3476(86)80112-3 · DOI · Paper page
  7. Rosenfeld, 1987, Somatomedin action and tissue growth-factor receptors, In: Robbins R, Melmed S (eds) Acromegaly. Plenum Press, New York, pp, 45
  8. Lowe, 1991, Biological actions of the insulin-like growth factors, In: LeRoith D (ed) Insulin-like Growth Factors: Molecular and Cellular Aspects. CRC Press, Boca Raton, FL, pp, 49
  9. Rotwein, 1991, Structure, evolution, expression and regulation of insulin-like growth factors I and II., Growth Factors, 5, 3, 10.3109/08977199109000267 · DOI · Paper page
  10. Jones, 1995, Insulin-like growth factors and their binding proteins: biological actions., Endocr Rev, 16, 3
  11. Nissley, 1991, Insulin-like growth factor receptors., Growth Factors, 5, 29, 10.3109/08977199109000269 · DOI · Paper page
  12. Kornfeld, 1992, Structure and function of the mannose 6-phosphate/insulin-like growth factor II receptors., Annu Rev Biochem, 61, 307, 10.1146/annurev.bi.61.070192.001515 · DOI · Paper page
  13. Oh, 1998, IGF-independent actions of IGFBPs, In: Takano K, Hizuka N, Takahashi S-I (eds) Molecular Mechanisms to Regulate the Activities of Insulin-Like Growth Factors. Elsevier, Amsterdam, pp, 123
  14. Jones, 1993, Insulin-like growth factor binding protein 1 stimulates cell migration and binds to the α5β1 integrin receptor by means of its Arg-Gly-Asp sequence., Proc Natl Acad Sci USA, 90, 10553, 10.1073/pnas.90.22.10553 · DOI · Paper page
  15. Oh, 1993, Demonstration of receptors for insulin-like growth factor binding protein-3 on Hs578T human breast cancer cells., J Biol Chem, 268, 26045, 10.1016/S0021-9258(19)74273-2 · DOI · Paper page
  16. Andress, 1995, Heparin modulates the binding of insulin-like growth factor (IGF) binding protein-5 to a membrane protein in osteoblastic cells., J Biol Chem, 270, 28289, 10.1074/jbc.270.47.28289 · DOI
  17. Mohan, 1995, Studies on the mechanisms by which insulin-like growth factor (IGF) binding protein-4 (IGFBP-4) and IGFBP-5 modulate IGF actions in bone cells., J Biol Chem, 270, 20424, 10.1074/jbc.270.35.20424 · DOI · Paper page
  18. Oh, 1993, Insulin-like growth factor (IGF)-independent action of IGF-binding protein-3 in Hs578T human breast cancer cells., J Biol Chem, 268, 14964, 10.1016/S0021-9258(18)82426-7 · DOI · Paper page
  19. Oh, 1996, Antiproliferative actions of insulin-like growth factor binding protein (IGFBP)-3 in human breast cancer cells., Prog Growth Factor Res, 6, 503, 10.1016/0955-2235(95)00025-9 · DOI
  20. Rajah, 1997, Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-β1 on programmed cell death through a p53- and IGF-independent mechanism., J Biol Chem, 272, 12181, 10.1074/jbc.272.18.12181 · DOI · Paper page
  21. Bork, 1993, The modular architecture of a new family of growth regulators related to connective tissue growth factor., FEBS Lett, 327, 125, 10.1016/0014-5793(93)80155-N · DOI · Paper page
  22. Oh, 1996, Synthesis and characterization of insulin-like growth factor binding protein (IGFBP-7)., J Biol Chem, 271, 30322, 10.1074/jbc.271.48.30322 · DOI · Paper page
  23. Kim, 1997, Identification of a family of low-affinity insulin-like growth factor binding proteins (IGFBPs): characterization of connective tissue growth factor as a member of the IGFBP superfamily., Proc Natl Acad Sci USA, 94, 12981, 10.1073/pnas.94.24.12981 · DOI · Paper page
  24. Hwa, 1999, Insulin-like growth factor binding proteins: a proposed superfamily., Acta Paediatr Suppl, 428, 37, 10.1111/j.1651-2227.1999.tb14349.x · DOI
  25. Kelley, 1996, Insulin-like growth factor-binding proteins (IGFBPs) and their regulatory dynamics., Int J Biochem Cell Biol, 28, 619, 10.1016/1357-2725(96)00005-2 · DOI · Paper page
  26. Rajaram, 1997, Insulin-like growth factor-binding proteins in serum and other biological fluids: regulation and functions., Endocr Rev, 18, 801
  27. Rosenfeld, 1990, Insulin-like growth factor-binding proteins., Recent Prog Horm Res, 46, 99
  28. Luthman, 1989, Human insulin-like growth-factor-binding protein: low-molecular-mass form: protein sequence and cDNA cloning., Eur J Biochem, 180, 259, 10.1111/j.1432-1033.1989.tb14641.x · doi:10.1111/j.1432-1033.1989.tb14641.x
  29. Lee, 1988, Insulin-like growth factor (IGF) binding protein complementary deoxyribonucleic acid from human HEP G2 hepatoma cells: predicted protein sequence suggests an IGF binding domain different from those of the IGF-I and IGF-II receptors., Mol Endocrinol, 2, 404, 10.1210/mend-2-5-404 · DOI
  30. Brinkman, 1988, Isolation and characterization of a cDNA encoding the low molecular weight insulin-like growth factor binding protein (IBP-1)., EMBO J, 7, 2417, 10.1002/j.1460-2075.1988.tb03087.x · DOI
  31. Grundmann, 1988, Cloning of cDNA encoding human placental protein 12 (PP12): Binding protein for IGF-1 and somatomedin., Nucleic Acids Res, 16, 8711, 10.1093/nar/16.17.8711 · doi:10.1093/nar/16.17.8711
  32. Brewer, 1988, Cloning, characterization, and expression of a human insulin-like growth factor binding protein., Biochem Biophys Res Commun, 152, 1289, 10.1016/S0006-291X(88)80425-X · DOI · Paper page
  33. Julkunen, 1988, Primary structure of human insulin-like growth factor-binding protein/placental protein 12 and tissue-specific expression of its mRNA., FEBS Lett, 236, 295, 10.1016/0014-5793(88)80041-3 · DOI · Paper page
  34. Hossenlopp, 1986, Analysis of serum insulin-like growth factor binding proteins using Western blotting: use of the method for titration of the binding proteins and competitive binding studies., Anal Biochem, 154, 138, 10.1016/0003-2697(86)90507-5 · DOI · Paper page
  35. Akaogi, 1996, Synergistic growth stimulation of mouse fibroblasts by tumor-derived adhesion factor with insulin-like growth factors and insulin., Cell Growth Differ, 7, 1671
  36. Burren, 1999, Binding properties and distribution of insulin-like growth factor binding protein-related protein 3 (IGFBP-rP3/NovH), an additional member of the IGFBP superfamily., J Clin Endocrinol Metab, 84, 1096
  37. Kumar, 1999, Identification and cloning of a connective tissue growth factor-like cDNA from human osteoblasts encoding a novel regulator of osteoblast functions., J Biol Chem, 274, 17123, 10.1074/jbc.274.24.17123 · DOI
  38. Murphy, 1993, Identification and characterization of genes differentially expressed in meningiomas., Cell Growth Differ, 4, 715
  39. Yamauchi, 1994, Purification and molecular cloning of prostacyclin-stimulating factor from serum-free conditioned medium of human diploid fibroblast cells., Biochem J, 303, 591, 10.1042/bj3030591 · DOI
  40. Akaogi, 1994, Cell adhesion activity of a 30-kDa major secreted protein from human bladder carcinoma cells., Biochem Biophys Res Commun, 198, 1046, 10.1006/bbrc.1994.1149 · doi:10.1006/bbrc.1994.1149
  41. Bradham, 1991, Connective tissue growth factor: a cysteine-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10., J Cell Biol, 114, 1285, 10.1083/jcb.114.6.1285 · DOI · Paper page
  42. Martinerie, 1992, Physical mapping of human loci homologous to the chicken nov proto-oncogene., Oncogene, 7, 2529
  43. Pennica, 1998, WISP genes are members of the connective tissue growth factor family that are up-regulated in Wnt-1-transformed cells and aberrantly expressed in human colon tumors., Proc Natl Acad Sci USA, 95, 14717, 10.1073/pnas.95.25.14717 · DOI · Paper page
  44. Zhang, 1998, Identification of rCop-1, a new member of the CCN protein family, as a negative regulator for cell transformation., Mol Cell Biol, 18, 6131, 10.1128/MCB.18.10.6131 · DOI
  45. Hashimoto, 1998, Expression of the Elm1 gene, a novel gene of the CCN (connective tissue growth factor, Cyr61/Cef10, and neuroblastoma overexpressed gene) family, suppresses in vivo tumor growth and metastatis of K-1735 murine melanoma cells., J Exp Med, 187, 289, 10.1084/jem.187.3.289 · DOI
  46. Zumbrunn, 1996, Primary structure of a putative serine protease specific for IGF-binding proteins., FEBS Lett, 398, 187, 10.1016/S0014-5793(96)01229-X · DOI
  47. Hu, 1998, Human HtrA, an evolutionarily conserved serine protease identified as a differentially expressed gene product in osteoarthritic cartilage., J Biol Chem, 273, 34406, 10.1074/jbc.273.51.34406 · DOI
  48. Lassalle, 1996, ESM-1 is a novel human endothelial cell-specific molecule expressed in lung and regulated by cytokines., J Biol Chem, 271, 20458, 10.1074/jbc.271.34.20458 · DOI · Paper page
  49. Baxter, 1998, Recommendations for nomenclature for the insulin-like growth factor binding protein (IGFBP) superfamily., J Clin Endocrinol Metab, 83, 3213, 10.1210/jcem.83.9.5083 · DOI
  50. Shimasaki, 1991, Identification and molecular characterization of insulin-like growth factor binding Proteins (IGFBP-1, -2, -3, -4, -5 and -6)., Prog Growth Factor Res, 3, 243, 10.1016/0955-2235(91)90003-M · DOI · Paper page
  51. Schoen, 1995, Cloning and characterization of a chick embryo cDNA and gene fro IGF-binding protein-2., J Mol Endocrinol, 15, 49, 10.1677/jme.0.0150049 · doi:10.1677/jme.0.0150049
  52. Allander, 1995, Conservation of IGFBP structure during evolution: cloning of chicken insulin-like growth factor binding protein-5., Prog Growth Factor Res, 6, 159, 10.1016/0955-2235(96)00011-7 · DOI
  53. James, 1993, A highly-conserved insulin-like growth factor-binding protein (IGFBP-5) is expressed during myoblast differentiation., J Biol Chem, 266, 22305, 10.1016/S0021-9258(18)41529-3 · DOI
  54. Upton, 1993, Evolution of insulin-like growth factor binding proteins., Growth Regul, 3, 29
  55. Reinecke, 1998, The phylogeny of the insulin-like growth factors., Int Rev Cytol, 183, 1, 10.1016/S0074-7696(08)60142-4 · DOI · Paper page
  56. Thompson, 1994, CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice., Nucleic Acids Res, 22, 4673, 10.1093/nar/22.22.4673 · DOI · Paper page
  57. Shimasaki, 1991, Isolation and molecular cloning of insulin-like growth factor-binding protein-6., Mol Endocrinol, 5, 938, 10.1210/mend-5-7-938 · DOI · Paper page
  58. Neumann, 1998, Identification of O-glycosylation sites and partial characterization of carbohydrate structure and disulfide linkages of human insulin-like growth factor binding protein 6., Biochem J, 37, 6572, 10.1021/bi972894e · DOI
  59. Forbes, 1998, Localization of an insulin-like growth factor (IGF) binding site of bovine IGF binding protein-2 using disulfide mapping and deletion mutation analysis of the C-terminal domain., J Biol Chem, 273, 4647, 10.1074/jbc.273.8.4647 · doi:10.1074/jbc.273.8.4647
  60. Neumann, 1999, The N-terminal disulfide linkages of human insulin-like growth factor-binding protein-6 (hIGFBP-6) and hIGFBP-1 are different as determined by mass spectrometry., J Biol Chem, 274, 14587, 10.1074/jbc.274.21.14587 · DOI
  61. Hashimoto, 1997, Binding sites and binding properties of binary and ternary complexes of insulin-like growth factor-II (IGF-II), IGF-binding protein-3, and acid-labile subunit., J Biol Chem, 272, 27936, 10.1074/jbc.272.44.27936 · DOI
  62. Kalus, 1998, Structure of the IGF-binding domain of the insulin-like growth factor-binding protein-5 (IGFBP-5): implications for IGF and IGF-I receptor interactions., EMBO J, 17, 6558, 10.1093/emboj/17.22.6558 · DOI · Paper page
  63. Rodakis, 1983, The B multigene family of chorion proteins in saturniid silkmoths., J Mol Evol, 19, 322, 10.1007/BF02101635 · doi:10.1007/bf02101635
  64. Hatfull, 1993, DNA sequence, structure and gene expression of mycobacteriophage L5: a phage system for mycobacterial genetics., Mol Microbiol, 7, 395, 10.1111/j.1365-2958.1993.tb01131.x · DOI · Paper page
  65. Jordi, 1989, Nucleotide sequence of the gene coding for the peplomer protein (= spike protein) of infectious bronchitis virus, strain D274., Nucleic Acids Res, 17, 6726, 10.1093/nar/17.16.6726 · doi:10.1093/nar/17.16.6726
  66. Evans, 1990, A gene from pea (Pisum sativum L.) with homology to metallothion genes., FEBS Lett, 262, 29, 10.1016/0014-5793(90)80145-9 · doi:10.1016/0014-5793(90)80145-9
  67. Bohn, 1980, New placental protein (PP15) with immunosuppressive properties., Arch Gynecol, 230, 167, 10.1007/BF02108272 · doi:10.1007/bf02108272
  68. Zapf, 1988, Isolation and NH2-terminal amino acid sequences of rat serum carrier proteins for insulin-like growth factors., Biochem Biophys Res Commun, 156, 1187, 10.1016/S0006-291X(88)80758-7 · doi:10.1016/s0006-291x(88)80758-7
  69. Ceda, 1991, Differential effects of insulin-like growth factor (IGF)-I and IGF-II on the expression of IGF binding proteins (IGFBPs) in a rat neuroblastoma cell line: isolation and characterization of two forms of IGFBP-4., Endocrinology, 128, 2815, 10.1210/endo-128-6-2815 · DOI
  70. Bach, 1992, Human insulin-like growth factor binding protein-6 is O-glycosylated., Biochem Biophys Res Commun, 186, 301, 10.1016/S0006-291X(05)80807-1 · DOI
  71. Conover, 1993, Regulation and biological effect of endogenous insulin-like growth factor binding protein-5 in human osteoblastic cells., J Clin Endocrinol Metab, 76, 1153
  72. Bach, 1993, Rat PC12 pheochromocytoma cells synthesize insulin-like growth factor-binding protein-6., Endocrinology, 133, 990, 10.1210/endo.133.3.7689963 · doi:10.1210/endo.133.3.7689963
  73. Claussen, 1995, Regulation of insulin-like growth factor (IGF)-binding protein-6 and mannose 6-phosphate/IGF-II receptor expression in IGF-IL-overexpressing NIH 3T3 cells., Mol Endocrinol, 9, 902
  74. Coverley, 1997, Phosphorylation of insulin-like growth factor binding proteins., Mol Cell Endocrinol, 128, 1, 10.1016/S0303-7207(97)04032-X · DOI
  75. Jones, 1991, Phosphorylation of insulin-like growth factor (IGF)-binding protein-1 in cell culture and in vivo: effects on affinity for IGF-I., Proc Natl Acad Sci USA, 88, 7481, 10.1073/pnas.88.17.7481 · DOI · Paper page
  76. Westwood, 1997, Purification and characterization of the insulin-like growth factor-binding protein-1 phosphoform found in normal plasma., Endocrinology, 138, 1130, 10.1210/endo.138.3.5020 · DOI
  77. Frost, 1991, Insulin-like growth factor binding protein-1 is phosphorylated by cultured human endometrial cells and multiple protein kinases in vitro., J Biol Chem, 266, 18082, 10.1016/S0021-9258(18)55239-X · DOI
  78. Jones, 1993, Identification of the sites of phosphorylation in sinulin-like growth factor binding protein-1: regulation of its affinity by phosphorylation of serine 101., J Biol Chem, 268, 1125, 10.1016/S0021-9258(18)54050-3 · DOI
  79. Peterkofsky, 1998, Phosphorylation of rat insulin-like growth factor binding protein-1 does not affect its biological properties., Arch Biochem Biophys, 357, 101, 10.1006/abbi.1998.0797 · DOI
  80. Hoeck, 1994, Identification of the major sites of phosphorylation in IGF binding protein-3., J Cell Biochem, 56, 262, 10.1002/jcb.240560220 · doi:10.1002/jcb.240560220
  81. Coverley, 1995, Regulation of insulin-like growth factor (IGF) binding protein-3 phosphorylation by IGF-I., Endocrinology, 136, 5778, 10.1210/endo.136.12.7588336 · doi:10.1210/endo.136.12.7588336
  82. Malthiery, 1987, Primary structure of human thyroglobulin deduced from the sequence of its 8448-base complementary DNA., Eur J Biochem, 165, 491, 10.1111/j.1432-1033.1987.tb11466.x · DOI · Paper page
  83. Lenarcic, 1998, Thyropins — new structurally related proteinase inhibitors., Biol Chem, 379, 105
  84. Bevec, 1996, Major histocompatibility compex class II-associated p41 invariant chain fragment is a strong inhibitor of lysosomal cathepsin L., J Exp Med, 183, 1331, 10.1084/jem.183.4.1331 · DOI · Paper page
  85. Mann, 1989, Amino acid sequence of mouse nidogen, a multidomain basement membrane protein with binding activity for laminin, collagen IV and cells., EMBO J, 8, 65, 10.1002/j.1460-2075.1989.tb03349.x · DOI
  86. Morabito, 1994, Molecular cloning of bullfrog saxipholin: a unique relative of the transferrin family that binds saxitoxin., Proc Natl Acad Sci USA, 91, 2478, 10.1073/pnas.91.7.2478 · DOI
  87. Morabito, 1995, Molecular cloning of bullfrog saxiphilin: a unique relative of the transferrin family that binds saxitoxin. (Correction)., Proc Natl Acad Sci USA, 92, 6651, 10.1073/pnas.92.14.6651 · doi:10.1073/pnas.92.14.6651
  88. Szala, 1990, Molecular cloning of cDNA for the carcinoma-associated antigen GA733–2., Proc Natl Acad Sci USA, 87, 3542, 10.1073/pnas.87.9.3542 · DOI
  89. Yamashita, 1996, A novel cysteine protease inhibitor of the egg of Chum salmon, containing a cysteine-rich thyroglobulin-like motif., J Biol Chem, 271, 1282, 10.1074/jbc.271.3.1282 · DOI
  90. Lenarcic, 1997, Equistatin, a new inhibitor of cysteine proteinases from Actinia equina, is structurally related to thyroglobulin type-I domain., J Biol Chem, 272, 13899, 10.1074/jbc.272.21.13899 · DOI
  91. Kimura, 1998, Entactin-2: a new member of basement membrane protein with high homology to entactin/nidogen., Exp Cell Res, 241, 36, 10.1006/excr.1998.4016 · DOI
  92. Jones, 1995, Cell migration: interactions among integrins, IGFs and IGFBPs., Prog Growth Factor Res, 6, 319, 10.1016/0955-2235(95)00015-1 · DOI
  93. Booth, 1996, Structure-function relationships in the heparin-binding c-terminal region of insulin-like growth factor binding protein-3., Growth Regul, 6, 206
  94. Fowlkes, 1997, Heparin-binding, highly basic regions within the thyroglobulin type-I repeat of insulin-like growth factor (IGF)-binding protleins (IGFBPs) -3, -5, and -6 inhibit IGFBP-4 degradation., Endocrinology, 138, 2280, 10.1210/endo.138.6.5182 · DOI
  95. Smith, 1994, Insulin-like growh factor-binding protein-3 (IGFBP-3) concentration in rat Sertoli cell-conditioned medium is regulated by a pathway involving association of IGFBP-3 with cell surface proteoglycans., Endocrinology, 135, 359, 10.1210/endo.135.1.7516869 · doi:10.1210/endo.135.1.7516869
  96. Jones, 1993, Extracellular matrix contains insulin-like growth factor binding protein-5: potentiation of the effects of IGF-I., J Cell Biol, 121, 679, 10.1083/jcb.121.3.679 · DOI · Paper page
  97. Giudice, 1990, Insulin-like growth factor binding proteins in maternal serum throughout gestation and in the puerperium: effects of a pregnancy-associated serum protease activity., J Clin Endocrinol Metab, 71, 806, 10.1210/jcem-71-4-806 · DOI · Paper page
  98. Cohen, 1992, Prostate specific antigen is an IGF binding protein-3 (IGFBP-3) protease found in seminal plasma., J Clin Endocrinol Metab, 75, 1046
  99. Cohen, 1994, Biological effects of prostate specific antigen (PSA) as an IGF binding protein-3 (IGFBP-3) protease., J Endocrinol, 142, 407, 10.1677/joe.0.1420407 · DOI · Paper page
  100. Clemmons, 1995, Role of insulin-like growth factor binding proteins in the control of IGF actions., Prog Growth Factor Res, 6, 357, 10.1016/0955-2235(95)00013-5 · DOI
  101. Collett-Solberg, 1996, The role of the insulin-like growth factor binding proteins and the IGFBP proteases in modulating IGF action., Endocrinol Metab Clin North Am, 25, 591, 10.1016/S0889-8529(05)70342-X · DOI · Paper page
  102. Hossenlopp, 1990, Evidence of enzymatic degradation of the insulin-like growth factor binding proteins in the 150K complex during pregnancy., J Clin Endocrinol Metab, 71, 797, 10.1210/jcem-71-4-797 · DOI · Paper page
  103. Fielder, 1994, Biochemical analysis of prostate specific antigen-proteolyzed insulin-like growth factor binding protein-3., Growth Regul, 1, 164
  104. Lalou, 1996, A proteolytic fragment of insulin-like growth factor (IGF) binding protein-3 that fails to bind IGFs inhibits the mitogenic effects of IGF-I and insulin., Endocrinology, 137, 3206, 10.1210/endo.137.8.8754741 · doi:10.1210/endo.137.8.8754741
  105. Lalou, 1997, Proteolytic fragments of insulin-like growth factor binding protein-3: N-terminal sequences and relationships between structure and biological activity., C R Acad Sci III, 320, 621, 10.1016/S0764-4469(97)85695-8 · doi:10.1016/s0764-4469(97)85695-8
  106. Vorwerk, 1998, Insulin and IGF binding by IGFBP-3 fragments derived from proteolysis, baculovirus expression and normal human urine., J Clin Endocrinol Metab, 83, 1392, 10.1210/jcem.83.4.4858 · doi:10.1210/jcem.83.4.4858
  107. Cheung, 1994, Glucocorticoid regulation of an insulin-like growth factor-binding protein-4 protease produced by a rat neuronal cell line., Endocrinology, 135, 1328, 10.1210/endo.135.4.7523095 · doi:10.1210/endo.135.4.7523095
  108. Chernausek, 1995, Proteolytic cleavage of insulin-like growth factor binding protein 4 (IGFBP-4): localization of cleavage sit to non-homologous region of native IGFBP-4., J Biol Chem, 270, 11377, 10.1074/jbc.270.19.11377 · doi:10.1074/jbc.270.19.11377
  109. Andress, 1992, Human osteoblast-derived insulin-like growth factor (IGF) binding protein 5 stimulates osteoblast mitogenesis and potentiates IGF action., J Biol Chem, 267, 22467, 10.1016/S0021-9258(18)41695-X · DOI · Paper page
  110. Andress, 1993, Carboxy-truncated insulin-like growth factor binding protein-5 stimulates mitogenesis in osteoblast-like cells., Biochem Biophys Res Commun, 195, 25, 10.1006/bbrc.1993.2004 · DOI
  111. Spencer, 1995, A 3-dimensional model for the insulin-like growth factor binding proteins (IGFBPs); supporting evidence using the structural determinants of the IGF binding site on IGFBP-3., Prog Growth Factor Res, 6, 209, 10.1016/0955-2235(96)00008-7 · doi:10.1016/0955-2235(96)00008-7
  112. Baxter, 1995, Modulations of human IGF binding protein-3 activity by structural modification., Prog Growth Factor Res, 6, 215, 10.1016/0955-2235(95)00004-6 · doi:10.1016/0955-2235(95)00004-6
  113. Firth, 1998, Structural determinants of ligand and cell surface binding of insulin-like growth factor-binding protein-3., J Biol Chem, 273, 2631, 10.1074/jbc.273.5.2631 · DOI
  114. Yamanaka, 1997, Inhibition of insulin receptor activation by insulin-like growth factor binding proteins., J Biol Chem, 272, 30729, 10.1074/jbc.272.49.30729 · DOI
  115. Qin, 1998, Structure-function analysis of the human insulin-like growth factor binding protein-4., J Biol Chem, 273, 23509, 10.1074/jbc.273.36.23509 · doi:10.1074/jbc.273.36.23509
  116. Hobba, 1996, The insulin-like growth factor (IGF) binding site of bovine insulin-like growth factor binding protein-2 (bIGFBP-2) probed by iodination., J Biol Chem, 271, 30529, 10.1074/jbc.271.48.30529 · doi:10.1074/jbc.271.48.30529
  117. Hobba, 1998, Alanine screening mutagenesis established tyrosine 60 of bovine insulin-like growth factor binding protein-2 as a determinant of insulin-like growth factor binding., J Biol Chem, 273, 19691, 10.1074/jbc.273.31.19691 · doi:10.1074/jbc.273.31.19691
  118. Brinkman, 1991, Mutations in the C-terminal part of insulin-like growth factor (IGF)-binding protein-1 result in dimer formation and loss of IGF binding capacity., Mol Endocrinol, 5, 987, 10.1210/mend-5-7-987 · doi:10.1210/mend-5-7-987
  119. Bramani, 1999, Amino acids within the extracellular matrix (ECM) binding region (201–218) of rat insulin-like growth factor binding protein (IGFBP-5) are important determinants in binding IGF-I., J Mol Endocrinol, 23, 117, 10.1677/jme.0.0230117 · doi:10.1677/jme.0.0230117
  120. Parker, 1998, Binding of insulin-like growth factor (IGF)-binding protein 5 to smooth-muscle cell extracellular matrix is a major determinant of the cellular response to IGF-I., Mol Biol Cell, 9, 2383, 10.1091/mbc.9.9.2383 · DOI
  121. Ho, 1997, Characterization of truncated insulin-like growth factor-binding protein-2 in human milk., Endocrinology, 138, 3811, 10.1210/endo.138.9.5415 · doi:10.1210/endo.138.9.5415
  122. Wang, 1988, Isolation of a biologically active fragment from the carboxy terminus of the fetal rat binding protein for insulin-like growth factors., Biochem Biophys Res Commun, 157, 718, 10.1016/S0006-291X(88)80309-7 · doi:10.1016/s0006-291x(88)80309-7
  123. Yamanaka, 1999, Characterization of insulin-like growth factor binding protein-3 (IGFBP-3) binding to human breast cancer cells., Endocrinology, 140, 1319, 10.1210/endo.140.3.6566 · doi:10.1210/endo.140.3.6566
  124. Collett-Solberg, 1998, Identification of novel high molecular weight insulin-like growth factor-binding protein-3 association proteins in human serum., J Clin Endocrinol Metab, 83, 2843
  125. Twigg, 1998, Insulin-like growth factor-binding protein-5 complexes with the acid-labile subunit. Role of the carboxyl-terminal domain., J Biol Chem, 273, 28791, 10.1074/jbc.273.44.28791 · DOI
  126. Hynes, 1992, Integrins: versatility, modulation, and signaling in cell adhesion., Cell, 69, 11, 10.1016/0092-8674(92)90115-S · DOI · Paper page
  127. Fowlkes, 1996, Characterization of glycosaminoglycan-binding domains present in insulin-like growth factor-binding protein-3., J Biol Chem, 271, 14676, 10.1074/jbc.271.25.14676 · doi:10.1074/jbc.271.25.14676
  128. Parker, 1996, Identification of the extracellular matrix binding site for insulin like growth factor binding protein-5., J Biol Chem, 271, 13523, 10.1074/jbc.271.23.13523 · DOI
  129. Rees, 1998, Inhibition of IGFBP-5 binding to extracellular matric and IGF-I-stimulated DNA synthesis by a peptide fragment of IGFBP-5., J Cell Biochem, 71, 375, 10.1002/(SICI)1097-4644(19981201)71:3<375::AID-JCB6>3.0.CO;2-M · doi:10.1002/(sici)1097-4644(19981201)71:3<375::aid-jcb6>3.0.co;2-m
  130. Abrass, 1997, Heparin binding domain of insulin-like growth factor binding protein-5 stimulates mesangial cell migration, Am J Physiol, 273, F899
  131. Gorlich, 1996, Nucleocytoplasmic transport., Science, 271, 1513, 10.1126/science.271.5255.1513 · DOI · Paper page
  132. Radulescu, 1994, Nuclear localization signal in insulin-like growth factor-binding protein type 3., Trends Biochem Sci, 19, 278, 10.1016/0968-0004(94)90004-3 · doi:10.1016/0968-0004(94)90004-3
  133. Li, 1997, Nuclear transport of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in opossum kidney cells., Endocrinology, 138, 1763, 10.1210/endo.138.4.5176 · DOI
  134. Jaques, 1997, Nuclear localization of insulin-like growth factor binding protein-3 in a lung cancer cell line., Endocrinology, 138, 1767, 10.1210/endo.138.4.5177 · DOI
  135. Wraight, 1998, Intranuclear localization of insulin-like growth factor binding protein-3 (IGFBP-3) during cell division in human keratinocytes., J Invest Dermatol, 111, 239, 10.1046/j.1523-1747.1998.00258.x · DOI
  136. Schedlich, 1998, Insulin-like growth factor-binding protein (IGFBP)-3 and IGFBP-3 share a common nuclear transport pathway in T47D human breast carcinoma cells., J Biol Chem, 273, 18347, 10.1074/jbc.273.29.18347 · DOI · Paper page
  137. Imai, 1997, Protease-resistant form of insulin-like growth factor-binding protein 5 is an inhibitor of insulin-like growth factor-I actions on porcine smooth muscle cells in culture., J Clin Invest, 100, 2596, 10.1172/JCI119803 · DOI
  138. Rees, 1998, A protease-resistant form of insulin-like growth factor (IGF) binding protein 4 inhibits IGF-I actions., Endocrinology, 139, 4182, 10.1210/endo.139.10.6266 · DOI
  139. Leal, 1997, The Type V transforming growth factor b receptor is the putative insulin-like growth factor-binding protein 3 receptor., J Biol Chem, 272, 20572, 10.1074/jbc.272.33.20572 · DOI · Paper page
  140. Leal, 1999, Interactions of high affinity insulin-like growth factor-binding proteins with the type V transforming growth factor-β receptor in mink lung epithelial cells., J Biol Chem, 274, 6711, 10.1074/jbc.274.10.6711 · DOI
  141. Andress, 1998, Insulin-like growth factor-binding protein-5 (IGFBP-5) stimulates phosphorylation of the IGFBP-5 receptor, Am J Physiol, 274, E744
  142. Ehrenborg, 1992, Contiguous localization of the genes encoding human insulin-like growth factor binding proteins 1 (IGFBP1) and 3 (IGFBP3) on chromosome 7., Genomics, 12, 497, 10.1016/0888-7543(92)90440-4 · doi:10.1016/0888-7543(92)90440-4
  143. Swisshelm, 1995, Enhanced expression of an insulin growth factor-like binding protein (mac25) in senescent human mammary epithelial cells and induced expression with retinoic acid., Proc Natl Acad Sci USA, 92, 4472, 10.1073/pnas.92.10.4472 · DOI
  144. Kato, 1996, A follistatin-like gene, mac25, may act as a growth suppressor of osteosarcoma cells., Oncogene, 12, 1361
  145. Burger, 1998, Down-regulation of T1A12/mac25, a novel insulin-like growth factor binding protein related gene, is associated with disease progression in breast carcinomas., Oncogene, 16, 2459, 10.1038/sj.onc.1201772 · DOI
  146. Hwa, 1998, Characterization of insulin-like growth factor binding protein-related protein 1 in prostate cells., J Clin Endocrinol Metab, 83, 4355
  147. Sprenger, 1999, Insulin-like growth factor binding protein-related protein 1 (IGFBP-rP1) is a potential tumor suppressor protein for prostate cancer., Cancer Res, 59, 2370
  148. Damon, 1997, Developmental regulation of Mac25/insulin-like growth factor-binding protein-7 expression in skeletal myogenesis., Exp Cell Res, 237, 192, 10.1006/excr.1997.3787 · doi:10.1006/excr.1997.3787
  149. Pereira, 1999, Parathyroid hormone increases mac25/insulin-like growth factor-binding protein-related protein-1 expression in cultured osteoblasts., Endocrinology, 140, 1998, 10.1210/endo.140.5.6692 · doi:10.1210/endo.140.5.6692
  150. Pereira, 1999, Cortisol enhances the expression of mac25/insulin-like growth factor-binding protein-related protein-1 in cultured osteoblasts., Endocrinology, 140, 228, 10.1210/endo.140.1.6411 · DOI
  151. Akaogi, 1996, Specific accumulation of tumor-derived adhesion factor in tumor bascular endothelial cells., Proc Natl Acad Sci USA, 93, 8384, 10.1073/pnas.93.16.8384 · DOI
  152. Inoguchi, 1986, Reducted serum-stimulatory activity on prostacyclin production by cultured aortic endothelial cells in diabetes mellitus., Haemostasis, 16, 447
  153. Inoguchi, 1989, Abnormality in porstacyclin-stimulatory activity in sera from diabetes., Metabolism, 38, 837, 10.1016/0026-0495(89)90229-1 · doi:10.1016/0026-0495(89)90229-1
  154. Groot, 1985, The role of thrombin in the regulation of the endothelial prostaglandin production., Biochim Biophys Acta, 846, 342, 10.1016/0167-4889(85)90004-7 · doi:10.1016/0167-4889(85)90004-7
  155. Rosenfeld, 1998, Editorial: The blind men and the elephant - a parable for the study of insulin-like growth factor binding proteins., Endocrinology, 139, 5, 10.1210/endo.139.1.5746 · doi:10.1210/endo.139.1.5746
  156. Masakado, 1995, Immunohistochemical localization of a novel peptide, prostacyclin-stimulating factor (PSF), in human tissues., Thromb Haemost, 74, 1407, 10.1055/s-0038-1649955 · doi:10.1055/s-0038-1649955
  157. Umeda, 1996, Prostacyclin-stimulating factor, novel protein, and diabetic angiopathy, Diabetes, 45, S111, 10.2337/diab.45.3.S111 · doi:10.2337/diab.45.3.s111
  158. Brigstock, 1999, The connective tissue growth factor/cysteine-rich 61/nephroblastoma overexpressed (CCN) family., Endocr Rev, 20, 189
  159. Lau, 1999, The CCN family of angiogenic regulators: the integrin connection., Exp Cell Res, 248, 44, 10.1006/excr.1999.4456 · DOI · Paper page
  160. Simmons, 1989, Identification of a phorbol ester-repressible v-src-inducible gene., Proc Natl Acad Sci USA, 86, 1178, 10.1073/pnas.86.4.1178 · DOI · Paper page
  161. Brigstock, 1997, Purification and characterization of novel heparin-binding growth factors in uterine secretory fluids., J Biol Chem, 272, 20275, 10.1074/jbc.272.32.20275 · DOI · Paper page
  162. Ball, 1998, Characterization of 16- to 20-kilodalton (kDa) connective tissue growth factors (CTGFs) and demonstration of proteolytic activity for 38-kDa CTGF in pig uterine luminal flushings., Biol Reprod, 59, 828, 10.1095/biolreprod59.4.828 · DOI
  163. Steffen, 1998, Characterization of cell-associated and soluble forms of connective tissue growth factor (CTGF) produced by fibroblast cells in vitro., Growth Factors, 15, 199, 10.3109/08977199809002117 · DOI
  164. Nakanishi, 1997, Cloning of a mRNA preferentially expressed in chondrocytes by differential display-PCR from a human chondrocytic cell line that is identical with connective tissue growth factor (CTGF) mRNA., Biochem Biophys Res Commun, 234, 206, 10.1006/bbrc.1997.6528 · DOI · Paper page
  165. Nishida, 1998, Demonstration of receptors specific for connective tissue growth factor on a human chondrocytic cell line (HCS-2/8)., Biochem Biophy Res Commun, 247, 905, 10.1006/bbrc.1998.8895 · DOI
  166. Igarashi, 1993, Regulation of connective tissue growth factor gene expression in human skin fibroblasts and during wound repair., Mol Biol Cell, 4, 637, 10.1091/mbc.4.6.637 · DOI · Paper page
  167. Grotendorst, 1996, A novel transforming growth factor β response element controls the expression of the connective tissue growth factor gene., Cell Growth Differ, 7, 469
  168. Frazier, 1996, Stimulation of fibroblast cell growth, matrix production, and granulation tissue formation by connective tissue growth factor., J Invest Dermatol, 107, 404, 10.1111/1523-1747.ep12363389 · DOI · Paper page
  169. Grotendorst, 1997, Connective tissue growth factor: a mediator of TGF-β action on fibroblasts., Cytokine Growth Factor Rev, 8, 171, 10.1016/S1359-6101(97)00010-5 · DOI · Paper page
  170. Kothapalli, 1997, Transforming growth factor β induces anchorage-independent growth of NRK fibroblasts via a connective tissue growth factor-dependent signaling pathway., Cell Growth Differ, 8, 61
  171. Kothapalli, 1998, Inhibition of TGF-β-stimulated CTGF gene expression and anchorage-independent growth by cAMP identifies a CTGF-dependent restriction point in the cell cycle., FASEB J, 12, 1151, 10.1096/fasebj.12.12.1151 · DOI
  172. Shimo, 1998, Inhibition of endogenous expression of connective tissue growth factor by its antisense oligonucleotide and antisense RNA suppresses proliferation and migration of vascular endothelial cells., J Biochem, 124, 130, 10.1093/oxfordjournals.jbchem.a022071 · DOI
  173. Oemar BS and Luscher, 1997, Connective tissue growth factor, friend or foe?, Arterioscler Thromb Vasc Biol, 17, 1483, 10.1161/01.ATV.17.8.1483 · DOI
  174. Haustein, 1998, Pathophysiology of scleroderma: an update., J Eur Acad Dermatol Vernereol, 11, 1, 10.1111/j.1468-3083.1998.tb00945.x · doi:10.1111/j.1468-3083.1998.tb00945.x
  175. Dammeier, 1998, Connective tissue growth factor: a novel regulator of mucosal repair and fibrosis in inflammatory bowel disease?, Int J Biochem Cell Biol, 30, 909, 10.1016/S1357-2725(98)00046-6 · DOI
  176. Yang, 1998, Identification of glycosylated 38-kDa connective tissue growth factor (IGFBP-related protein 2) and proteolytic fragments in human biological fluids, and up-regulation of IGFBP-rP2 by TGF-beta in Hs578T human breast cancer cells., J Clin Endocrinol Metab, 83, 2593
  177. Frazier, 1997, Expression of connective tissue growth factor mRNA in the fibrous stroma of mammary tumors., Int J Biochem Cell Biol, 29, 153, 10.1016/S1357-2725(96)00127-6 · DOI
  178. Joliot, 1992, Proviral rearrangements and overexpression of a new cellular gene (nov) in myeloblastosis-associated virus type I-induced nephroblastomas., Mol Cell Biol, 12, 10, 10.1128/MCB.12.1.10 · DOI · Paper page
  179. Martinerie, 1994, Structural analysis of the human nov proto-oncogene and expression in Wilms tumors., Oncogene, 9, 2729
  180. Martin, 1994, Regulation and actions of the insulin-like growth factor binding proteins, In: Kohler PO (ed) Current Opinion in Endocrinology and Diabetes. Current Science, Philadelphia, pp, 16
  181. Chevalier, 1998, novH: Differential expression in developing kidney and Wilms tumors., Am J Pathol, 152, 1563
  182. Martinerie, 1996, Regulation of nov by WT1: a potential role for nov in nephrogenesis., Oncogene, 12, 1479
  183. Scholz, 1996, Transcriptional down regulation of the nov proto-oncogenein fibroblasts transformed by p60v-src., Mol Cell Biol, 16, 481, 10.1128/MCB.16.2.481 · DOI
  184. Ryseck, 1991, Structure, mapping, and expression of fisp-12, a growth factor-inducible gene encoding a secreted cysteine-rich protein., Cell Growth Differ, 2, 225
  185. Kolesnilova, 1998, Human Cyr61-mediated enhancement of bFGF-induced DNA synthesis in human umbilical vein endothelial cells., Oncogene, 16, 747, 10.1038/sj.onc.1201572 · DOI
  186. Schutze, 1998, The human analog of murine cystein rich protein 16 is a 1α,25-dihydroxyvitamin D3 responsive immediate early gene in human fetal osteoblasts: regulation by cytokines, growth factors, and serum., Endocrinology, 139, 1761, 10.1210/endo.139.4.5954 · DOI
  187. Yang, 1991, Cyr61, product of a growth factor-inducible immediate early gene, is associated with the extracellular matrix and the cell surface., Cell Growth Differ, 2, 351
  188. Kireeva, 1998, Adhesion of human umbilical vein endothelial cells to the immediate-early gene product Cyr61 is mediated through integrinα vβ3., J Biol Chem, 273, 3090, 10.1074/jbc.273.5.3090 · DOI · Paper page
  189. Babic, 1998, CYR61, a product of a growth factor-inducible immediate early gene, promotes angiogenesis and tumor growth., Proc Natl Acad Sci USA, 95, 6355, 10.1073/pnas.95.11.6355 · DOI · Paper page
  190. Kireeva, 1997, Cyr61 and Fisp12 are both ECM-associated signaling molecules:activities, metabolism, and localization during development., Exp Cell Res, 233, 63, 10.1006/excr.1997.3548 · DOI
  191. Wong, 1997, Cyr61, product of a growth factor-inducible immediate-early gene, regulates chondrogenesis in mouse limb bud mesenchymal cells., Dev Biol, 192, 492, 10.1006/dbio.1997.8766 · DOI · Paper page
  192. Pilarsky, 1998, Expression of the extracellular matrix signaling molecule Cyr61 is downregulated in prostate cancer., Prostate, 36, 85, 10.1002/(SICI)1097-0045(19980701)36:2<85::AID-PROS3>3.0.CO;2-D · DOI
  193. Hainsworth, 1992, Rearrangement of chromosone 1p in breast cancer correlates with poor prognostic features., Br J Cancer, 66, 131, 10.1038/bjc.1992.229 · doi:10.1038/bjc.1992.229
  194. Gehring, 1995, The 1p deletion is not a reliable marker for the prognosis of patients with neuroblastoma., Cancer Res, 55, 5366
  195. Shin, 1993, Deletion mapping of chromosome 1p and 22q in pheochromocytoma., Jpn J Cancer, 84, 402, 10.1111/j.1349-7006.1993.tb00150.x · DOI
  196. Cadigan, 1997, Wnt signaling: a common theme in animal development., Genes Dev, 11, 3286, 10.1101/gad.11.24.3286 · DOI · Paper page
  197. Dale, 1998, Signal transduction by the Wnt family of ligands., Biochem J, 329, 209, 10.1042/bj3290209 · DOI · Paper page
  198. Lipinska, 1989, Identification, characterization, and mapping of the Escherichia coli htrA gene, whose product is essential for bacterial growth only at elevated temperatures., J Bacteriol, 171, 1574, 10.1128/JB.171.3.1574-1584.1989 · DOI · Paper page
  199. Doolittle, 1995, The multiplicity of domains in proteins., Annu Rev Biochem, 64, 287, 10.1146/annurev.bi.64.070195.001443 · DOI · Paper page
  200. Bartelt, 1977, The primary structure of the human pancreatic secretory trypsin inhibitor. Amino acid sequence of the reduced S-aminoethylated protein., Arch Biochem Biophys, 179, 189, 10.1016/0003-9861(77)90103-5 · DOI

200 of 213 shown

Cited by

See all 1,079

Metadata

Authors
Hwa, V., Oh, Y., & Rosenfeld, R. G.
Venue
Endocrine Reviews
Published
1999-12-01
Volume
20
Issue
6
Pages
761-787
ISSN
  • 0163-769X (ISSN-L)
  • 1945-7189
OpenAlex
W2144678487
Cited by
1,079
References
3
FWCI
25.96
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Insulin-Like Growth Factor-Binding Protein (IGFBP) Superfamily*. https://app.cochat.ai/papers/10.1210/edrv.20.6.0382
The paper
Hwa, V., Oh, Y., & Rosenfeld, R. G. (1999). The Insulin-Like Growth Factor-Binding Protein (IGFBP) Superfamily*. Endocrine Reviews. https://doi.org/10.1210/edrv.20.6.0382

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.